Webinar: Pediatric Behavioral Health; Best Practices for Primary Care (recorded live)

Feb. 2022Important Notices
"Watch the webinar recorded live Nov. 17, 2021, where Alin Severance, MD, medical director of Behavioral Health Services at UPMC Health Plan and associate medical director at Community Care Behavioral Health Organization, discusses the importance of pediatric behavioral health best practices for primary care.

During this hourlong session, Dr. Severance reviews the epidemiology of behavioral health conditions in children and adolescents, best practices for screening and treatment for the most common behavioral health disorders and when to seek referrals, and the range of referral and consultation resources available to support the care of pediatric patients.

Register or log in

You may earn continuing medical education (CME) credits for attending this webinar.*

*This activity is approved for the following credit: AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

*Provider is responsible for verifying CME eligibility.
"

Recent Announcements

Important announcement – Telehealth submissions

As of October 1, 2025, UPMC Health Plan continues to accept the submission of telehealth claims. Providers may conduct telehealth visits for UPMC Health Plan members in all UPMC Insurance products. UPMC Insurance products include UPMC Advantage group and individual products, UPMC for Life Medicare Advantage plans, UPMC for Kids CHIP plans, UPMC Community HealthChoices, and UPMC for You Medical Assistance plans.
Sep. 2025Important Notices

October 2025 UPMC for You and UPMC Community HealthChoices Formulary Update

Effective October 1st, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to non-participation in the Medicaid Drug Rebate Program.
Sep. 2025Pharmacy Updates

Biosimilar Medication Formulary Updates

Updates to formulary biosimilar medications for denosumab, eculizumab, and ustekinumab products
Sep. 2025Pharmacy Updates